English

This webpage discusses how Hepatitis A and Hepatitis B are preventable through vaccination.

This webpage discusses the opioid crisis is one of the greatest public health challenges facing the U.S., causing an unprecedented surge in overdose deaths, and fueling the rapid rise in new Hepatitis C infections from injection drug use in communities across the country. Find helpful infographics at the bottom of the page.

Browse the full library of downloadable ads for apps, including Grindr. These ads were piloted in Shelby County, TN and Clark County, NV, and received more than 9 million views in the two-week pilot period.

This poster shows how people do lots of things to protect their bodies – from exercise to skin care. The mpox vaccine can prevent and lessen the internal and external symptoms of mpox.

Remember the 80s? It’s long gone. Remember mpox? It’s still a thing. Focus group participants shared that they feel safe from mpox now that media coverage has waned. Use this poster to remind them that mpox still exists – but so does the safe, effective vaccine.

This poster discusses how to make sure the second dose of the mpox vaccine is on your travel list. Engaging in sex while traveling can increase exposure to mpox. Getting the second dose of the mpox vaccine before taking off can protect you when you travel and protect your partners when you get home

RAISE and NASTAD’s webinar, “Best Practices for Community Engagement from a Public Health Perspective,” took place on Wednesday, July 19. This webinar featured two speakers discussing community engagement best practices, from a public health perspective. The discussion focused on approaches to assessing community preferences for public health interventions. 

RAISE and NASTAD’s webinar, “Integrating Implementation Science Methods into Health Department HIV Programs & Evaluation,” took place on Wednesday, June 21, 2023. This webinar featured the New York City Department of Health and Mental Hygiene and the Philadelphia Department of Public Health’s efforts to incorporate implementation science methods into HIV programming and evaluation.

NASTAD, in collaboration with the CDC’s Division of Viral Hepatitis, developed the “Viral Hepatitis Testing: Health System Assessment Toolkit,” a comprehensive resource that includes information and considerations for creating a jurisdiction-specific health system assessment (HSA) in response to recently revised and expanded hepatitis B and C screening guidelines issued by the Centers for Disease Control and Prevention (CDC) and the U.S. Preventive Services Task Force.

On July 20, 2023, NASTAD hosted a webinar for the University of Washington Supporting Harm Reductions Programs team, “Measuring Syringe Coverage at SSPs: An Indicator for Equity and Needs-Based Distribution.” During this webinar, UW SHaRP shared tools and tips for syringe services programs interested in measuring syringe coverage among their program participants.